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Selenium is a trace element essential for human health that has received considerable
attention given its nutritional value. In this research, to solve the poor selenium tolerance of
lactic acid bacteria (LAB) and to select a strain with both high selenium uptake efficiency
and the ability to transform inorganic selenium into an organic form, five strains of LAB
were subjected to an experiment. The total amount of selenium was quantified using an
inductively coupled plasma-atomic emission spectrometer (ICP-AES). Selenium species
ii
were separated by anion-exchange chromatography and analyzed by inductively coupled
plasma-mass spectrometry (ICP-MS). The reduction of bacterial cell mass was solved with
an adjustment of the selenium addition time (12 h after incubation), and Bifidobacterium
bifidum BGN4 was found to be the most potent selenium-enriched strain. The results
showed that selenomethionine was the main organic selenium in selenium-enriched B.
bifidum BGN4. Considering that B. bifidum BGN4 is a well-known probiotic strain with
clinically proven beneficial effects, selenium-enriched B. bifidum BGN4 may provide dual
healthy functions as a daily supplement of selenium and for the regulation of intestinal
bacteria.
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Selenium is a micronutrient essential for the maintenance of human health and
also plays an important role in human diseases, such as cancer and cardiovascular
diseases [1-7]. The recommended daily allowance (RDA) of selenium is 55 µg.
Selenium deficiency can cause Keshan disease and Kashin-Beck disease, with high
fatality rates [8, 9]. Wei et al. [10] demonstrated that the dietary selenium intake
was useful in the suppression of the development of type 2 diabetes.
The bioactivity and toxicity of selenium are closely related to the selenium
species, and several studies have suggested that the organic form of selenium is
more bioavailable and less toxic than its inorganic form, although accurate
knowledge of the pertinent mechanism remains unknown [11]. Selenium in
elemental form is regarded as non-bioavailable when taken orally but less toxic
than organic and inorganic form. The LD50 for red elemental selenium is 6,700
mg/kg while LD50 is 7 mg/kg for sodium selenite [12] and 25.6 mg for
selenomethionine [13].
According to recent studies, some microorganisms, such as Saccharomyces
cerevisiae and Lactobacillus, showed the ability to uptake selenium and transform
the chemical form of inorganic selenium to the organic form [14, 15]. Yin et al. [16]
２
suggested that selenium-enriched Bifidobacterium longum displays tumor
inhibitory activity. Various strains of microorganisms were screened to select
strains with high selenium uptake efficiencies and the abilities to transform the
inorganic selenium to the organic form. By applying these selected microorganisms,
certain selenium-enriched foods, such as selenium-enriched yeast, wine, fermented
milk, mushrooms were developed [14, 16-21].
However, due to the poor selenium tolerance, the growth of selenium-enriched
bacteria was inhibited considerably simply by adding a small quantity of sodium
selenite [17]. Accordingly, the harvested cell mass and selenium concentrations in
selenium-enriched bacteria were not satisfactory.
Probiotics, especially lactic acid bacteria and Bifidobacteriium, have received
increasing attention in recent years owing to their function of balancing intestinal
microbial balance and some medical benefits, such as anti-inflammatory effects,
alleviation of lactose intolerance, relief of constipation, anticholesterolaemic
effects, anticancer activity, anti-inflammatory and tolerogenic immune responses
[22, 23].
Previous studies have shown limitations on the preparation of selenium-enriched
lactic acid bacteria attributing to the low yield of selenium enrichment and lethal
effect of selenium on the growth of bacterial cells. Thus, the objectives of this
study were to solve the reduction of cell mass due to the poor selenium tolerance of
３
lactic acid bacteria (LAB) and by quantifying the selenium uptake efficiencies and
the biotransformation abilities to select a promising strain capable of providing






Sodium selenite (Na2O3Se), sodium selenate decahydrate (Na2O4Se·10H2O),
seleno-DL-methionine (C5H11NO2Se) and se-(methyl) selenocysteine
hydrochloride (C4H9NO2Se·HCl) used as standards and the enzyme pronase E
(protease XIV type) were purchased from Sigma-Aldrich (St. Louis., MO, USA).
Phosphate buffered saline (PBS) was prepared by dissolving 8 g NaCl, 0.2 g KCl,
1.44 g Na2HPO4, and 7.4 g KH2PO4 in 1 L of de-ionized water (DW) with a final
pH of 7.4. The buffer was autoclaved at 121°C for 15 min before use.
2.1.2. Microorganisms
The experimental bacterial strains were obtained from the Food Microbiology
Laboratory of Seoul National University (Seoul, Korea).
５
2.2. Methods
2.2.1. Preparation of a selenium-enriched LAB samples
Five strains of Lactobacillus were used to prepare the selenium-enriched
probiotics. All of the stocks were stored at -80°C in cryogenic vials with 30% (v/v)
sterile glycerol (50% w/v) before use. First, they were cultured in MRS broth
(Becton, Dickson and Company, USA) with 0.05% (w/v) L-cysteine·HCl at 37°C
for 18 h. The culture media (15 mL) containing 1 mM of sodium selenite (added at
0 time or after being cultured for 12 h) were incubated in a water bath (37°C, 150
rpm) for 2 days. The selenium-enriched LAB samples were harvested by
centrifugation (139 × g, 20 min) and washed twice with DW. Finally, the samples
were freeze-dried.
2.2.2. Preparation of a 0.1 M sodium selenite (SS) solution
The sodium selenite (SS) stock solution (172.9 mg dissolved in 10 ml of DW)
was prepared and filtered by a 0.2 µm syringe filter. The 15 µL stock solution was
added to the culture medium (15 mL). The final selenium concentration in the
culture medium was 1 mM.
６
2.2.3. Quantification of total selenium, organic selenium and analysis
of selenium species
For the quantification of total selenium, dried cells harvested from 15 mL of
culture were dissolved with 8 mL of nitric acid overnight and then digested by a
microwave digestion system (Ethos 1, Milestone, Bergamo, Italy). The volume of
the dissolved samples was adjusted with DW to 50 mL. The total selenium was
quantified using an inductively coupled plasma-atomic emission spectrometer
(ICP-AES, Optima-4300 DV, Perkin Elmer, Norwalk, CT, USA).
For the extraction of the total selenium organic compounds and an assessment of
the selenium species, the selenium-enriched LAB powder was dissolved in 5 mL of
phosphate buffer containing 20 mg of pronase E and then incubated at 37°C for 16
h [24, 25]. The samples were then filtered through a sterile filter (0.45 µm, Pall
Corporation, Port Washington, NY). The determination of selenium species was
performed using an inductively coupled plasma mass spectrometer (ICP-MS,
Agilent 7700, Agilent Technologies, Tokyo, Japan) equipped with an octopole
collision cell. Chromatographic separations were performed using a Model 1260
HPLC pump (Agilent, Wilmington, DE, USA) as the delivery system. The
selenium species separations were carried out using a Hamilton (Reno, NV) PRP
X-100 anion exchange column (250 mm X 4.1 mm id, 10μm particles) at 40°C. The
flow rate was kept at 1 mL/min, and the injection volume was 20 μL. The detailed
７
HPLC analytic conditions are presented in Table 1 and ICP-MS operating
conditions were summarized in Table 2.
８
Table 1. Anion Exchange Chromatographic Parameters
Parameters
Column PRP X-100 (250 X 4.1 mm, 10 µm), Hamilton
Mobile phase A, 2 mMAmmonium Citrate in 2% Methanol
B, 10 mMAmmonium Citrate in 2% Methanol
Flow rate 1 mL/min
Injection Vol. 20 µL
Gradient 0-2 min 20% B
2-10 min 20-100% B
10-18 min 100% B
９
Table 2. ICP-MS parameters
Parameters
Forward Power 1550 W
Plasma Gas Flow Rate 10.5 L/mL
Carrier Gas Flow Rate 0.8 L/mL
Makeup Gas Flow Rate 0.30 L/min
Sample Depth 8.0 mm
Collision Gas (He Gas) Flow 3.5 mL/min
Quadrupole Bias -16 V
Octopole Bias -18 V
Isotopes Detection Type TRA
Isotopes monitored (m/z) 77Se, 78Se
１０
3. Statistical analysis
Experiments were performed in triplicate, and the data was shown as mean ±
standard deviation. Unpaired t-test and one-way analysis of variance (ANOVA)
with Duncan post-hoc test (p < 0.01) were performed with the statistics package
GNU R, version 3.1.2 [26].
１１
4. Results and Discussion
4.1. The effect of the selenium addition time on bacterial cell
mass
Though the preliminary screening process, the strains L. bulgaricus KCTC 3188,
L. acidophilus KCTC 3142, L. casei KFRI 704, L. brevis 353, and B. bifidum
BGN4 were selected and assessed experimentally to quantify the total selenium
content and the selenium species. Table 1 shows the dry weights of the
selenium-enriched LAB samples depending on the addition time of SS into the
growth medium. The addition of SS at 0 h inhibited the growth of L. bulgaricus
KCTC 3188, L. acidophilus KCTC 3142, L. casei KFRI 704, L. brevis 353, and B.
bifidum BGN4 by 40, 26.9, 41.9, 31.1 and 75.9%, respectively, compared to the
control group without SS (Table 3, p < 0.01). On the other hand, the addition of SS
at 12 h did not lead to a reduction of the cell mass (p > 0.01).
Selenium compounds can inhibit the growth of Staphylococcus aureus [27, 28]
but also can inhibit the growth of Lactobacillus and Bifidobacterium. Deng et al.
[17] reported that a concentration of SS which exceeds 10 µg/mg can inhibit the
growth of bacteria, and Yin et al. [16] showed that the biomass of L. brevis was
reduced by 59.3% when grown in a MRS medium containing 1 mM of SS. Since
１２
the addition of selenium at 12 h after incubation did not lead to a reduction of final
cell mass of LAB, the present method would be a good solution to overcome the
reduction of bacterial cell mass caused by poor selenium tolerance of LAB.
１３
Table 3. Dry weight of selenium-enriched LAB grown in MRS containing 1
mM (172.9 mg/L) of sodium selenite (SS)
Strain







L. bulgaricus KCTC 3188 15 ± 0.62* 24.3 ± 0.55 25 ± 0.38
L. acidophilus KCTC 3142 16.3 ± 0.40* 22.8 ± 0.42 22.3 ± 0.26
L. casei KFRI 704 15 ± 0.49* 25.6 ± 0.31 25.8 ± 0.56
L. brevis 353 21 ± 0.49* 31.1 ± 0.55 30.5 ± 0.81
B. bifidum BGN4 5.3 ± 0.50* 20.9 ± 0.53 22 ± 0.35
Data is shown as the mean ± SD from triplicate experiments.
*Values are significantly different compared to control group (p < 0.01).
１４
4.2. Total selenium and organic selenium contents in
selenium-enriched LAB quantified by ICP-AES
Total selenium quantification by nitric acid extraction using microwave oven
digestion could achieve a high recovery rate (96.6%) [29]. Meanwhile, the
oxidation states of selenium were altered by nitric acid [30]. Therefore, the method
in which nitric acid is applied is not appropriate for identifying the chemical form
of selenium. Enzymatic hydrolysis with proteinase K (pronase E) has been proven
as the most effective method for the quantification of organic selenium species
without altering their oxidation states [31]. Therefore, nitric acid digestion (Table 4)
and a proteolytic treatment were applied for the quantification of the total selenium
and the total organic selenium, respectively, in this study. Previously,
microorganisms such as Saccharomyces and LAB showed the ability to transform
the chemical form of tetravalent inorganic selenium in a culture medium into
elemental selenium and organic selenium [14, 32-34]. Based on Tables 4 and 5, L.
casei KFRI 704 showed relatively low levels of total and organic selenium
concentrations of 7.3 mg/g and 35 µg/g, respectively, while B. bifidum BGN4
showed the highest concentrations of total and organic selenium, amounting to 33.3
mg/g and 207.5 µg/g, respectively. Yan et al. [16] prepared selenium-enriched
Bifidobacterium longum with an organic selenium concentration of 81.6 µg/g.
Yeast is considered to be an effective selenium-enriching microorganism, and
commercial products typically contain from 1,000 to 2,000 micrograms of
１５
selenium per gram [35]. Thus, although the organic selenium contents were less
than 1% in total selenium, B. bifidum BGN4 was better at enriching selenium than
other microorganisms reported earlier, where the selenium source were added at the
beginning of the growth. By solving the poor selenium tolerance of LAB, a higher
concentration of selenium accumulated in LAB was achieved. The culture medium
turned into red color during the incubation with the addition of SS. According to
Xia et al. [36], the red color of the medium was attributed to the formation of
non-toxic elemental selenium after the experimental cells were treated with a high
selenium concentration (higher than 4 mg/L). The notable difference in the
selenium contents between the results with the nitric acid method and the
proteolytic treatment was mainly due to the formation of elemental selenium.
Considering both the harvested cell mass and the uptake efficiency, B. bifidum
BGN4 is the most desirable for use as selenium-enriched probiotics.
１６







L. bulgaricusKCTC3188 28.1 ± 0.01a 111.7 ± 0.16a
L. acidophilusKCTC3142 31.4 ± 0.00b 134.4 ± 1.18b
L. caseiKFRI 704 7.3 ± 0.00c 35± 0.20c
L. brevis 353 23.1 ± 0.01d 111.8 ± 0.86a
B. bifidumBGN4 33.3 ± 0.01e 207.5 ± 1.25d
Data is shown as themean ± SD from triplicate experiments.
a,b,c,d,e Values with different superscripts within the same columns indicate significant
differences.
１７
4.3. Comparison of the effect of different SS addition time on the
bacterial cell mass and uptake efficiency
The total and organic selenium contents in selenium-enriched B. bifidum BGN4 with SS
added at 6 h (33.3 mg/g, 224.1 µg/g) and 12 h (33.3 mg/g, 207.5 µg/g) showed no
significant differences (p > 0.01). However, the bacterial cell mass was significantly
decreased when selenium was added at 6 h (Table 5, p < 0.01). When selenium was added
at the beginning of the growth of B. bifidum BGN4, the growth was considerably retarded
(data not shown). The decrease of cell mass were 75.9% and 62.7%when SS was added at
0 h and 6 h after incubation.As expected, B. bifidumBGN4was very sensitive to selenium.
In the previous studies, a comparison of different selenium addition times was not
performed.
１８
Table 5. Comparison of the dryweights and the uptake efficiency ofB. bifidumBGN4














SS added at 6 h 8.3 ± 0.61 33.3 ± 0.02 224.1 ± 0.78
SS added at 12 h 20.9 ± 0.53 33.3 ± 0.01 207.5 ± 1.25
Data is shown as themean ± SD from triplicate experiments.
１９
4.4. Selenium species analysis byHPLC-ICP-MS
For the selenium species analysis, enzymatic hydrolysis using pronase E was done prior
to the species analysis step. Pronase E is a non-specific protease which is used regularly to
break down the peptide bonds of selenium-containing proteins. It is also considered as the
most effective protease [37].As shown in Figure 1, the major species in selenium-enriched
B. bifidumBGN4was selenomethionine, at 169.6 µg/g.
The previous study suggested that the relative bioavalibility value of selenomethionine
compared to SS was 147% for liver glutathione peroxidase activity and 336% for weight
gain in channel catfish which indicated that selenium allowance in diets of channel catfish
can be reduced when using selenomethionine instead of inorganic selenium [38]. Claire et
al. [39] suggested that selenomethionine inhibited the growth of the human tumor cell lines
(MCF-7/S breast carcinoma, DU-145 prostate cancer cells and UACC-375 melanoma) in
the range from 45 to 130 µMwhile growth inhibition of normal diploid fibroblasts required
1 mM selenomethionine, much higher than for the cancer cell lines. Considering
bioavalibility and toxicity, selenomethionine is appropriate supplemental form of selenium
for humans and animals [40].
The minimum requirement for the prevention of Keshan disease is 20 µg/day. The
physiological requirement for maximal glutathione peroxidase (GPx) and selenoprotein P
was estimated to be 45–50 µg/day and the requirement for iodothyronine 5 deiodinases
２０
(IDIs) is 30 µg/day. In addition, protection against some cancers, such as lung cancer and
prostate cancer, requires 120 µg/day [41]. B. bifidum BGN4 is considered as one of the
most promising probiotics given its clinically proven beneficial effects [42]. Research has
suggested that the oral feeding of B. bifidum BGN4 can prevent T cell-mediated
inflammatory bowel disease by the inhibition of disorderedT cell activation processes [43].
Since the low toxicity of elemental selenium, high bioactivity of selenomethionine and
the high selenium uptake efficiency of B. bifidum BGN4 shown in the current study,
selenium-enriched B. bifidum BGN4 may provide sufficient supplementation of dietary
seleniumand regulation of intestinal bacteria.
２１
Fig. 1. Chromatographic profiles of mixture of selenium standards obtained by
HPLC-ICP-MS
２２




The adjustment of selenium addition time (12 h after incubation) enhanced the cell mass
of the selenium-enriched LAB by overcoming the poor selenium tolerance of LAB. The
comparison of the selenium uptake efficiency of the various experimental LAB showed
that selenium-enriched B. bifidum BGN4was the most potent selenium-enriched probiotics
in this study. However, further researches are need to improve the biotransformation
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셀레늄은 우리 몸에 필수적인 미량 영양소로서 자유 라디칼의 생성을 억제
할 수 있는 글루타티온 과산화효소 (glutathione peroxidase)의 중요한 구성성
분으로 세포를 산화적 손상으로부터 보호하는 역할을 한다. 이 외에도 셀레늄
의 항암, 심혈관 질병 예방에 대한 연구 결과도 보고되는 등 영양소로서 역할
이 주목받고 있다. 셀레늄은 구조에 따라 독성과 생물학적 이용도가 다른데
유기 셀레늄이 무기 셀레늄보다 낮은 독성과 높은 생물학적 이용도를 가지고
있다고 보고되었다. 여러 미생물들이 셀레늄을 uptake하고 무기 셀레늄을 유
기 셀레늄으로 생물전환 할 수 있다는 능력이 보고되면서 많은 효모와 유산균
의 셀레늄 생물전환능력을 평가∙탐색하여 고효율의 균주를 선별하고, 이를 이
용하여 식품산업에 적용할 수 있는 셀레늄 강화 효모, 유산균을 제조한 사례
가 보고되었다. 하지만 대부분의 유산균이 셀레늄 내성이 약하여 배지에 적은
농도의 셀레늄을 첨가하여도 균의 성장에 억제가 일어나는 약점이 있었다. 따
라서, 본 연구의 목적은 약한 셀레늄 내성에 의한 유산균의 성장 억제를 해결
하고 보다 더 효율적으로 셀레늄 강화 유산균 제조를 도모하며, 5 균주의 유산
균 (L.bulgaricus KCTC 3188, L.acidophilus KCTC 3142, L. casei KFRI 704,
L.brevis 353, B.bifidum BGN4) 을 이용하여 총 셀레늄과 총 유기 셀레늄의
함량을 분석하여 셀레늄 uptake 효율이 높은 균주를 선택하고 종 분석을 하
는것이다. 연구결과, 유산균 배양 12시간 후 셀레늄을 첨가하는 방식으로 셀
레늄 첨가에 의한 유산균이 정상적인 생장 양상을 보였으며, 따라서 더욱 효
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율적으로 셀레늄 강화 유산균을 제조할 수 있었다. B. bifidum BGN4의 높은
셀레늄 uptake 효율과 무기 셀레늄을 유기 셀레늄으로 생물전환 하는 능력
역시 다른 균주들에 비해 우수하다는 것을 알 수 있었다.
주요어: 셀레늄, 생물전환, 유산균, BGN4, HPLC, ICP-MS
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